June 13, 2013 ·
Leave a comment
June 13, 2013 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in gastroenterology with a leading U.S. biopharmaceutical company.
The company, a global leader in drug development for products aiding patients in recovery from a variety of gastrointestinal surgeries, approached Thought Leader Select for support with planned initiatives with key opinion leaders and centers of excellence in the field.
Thought Leader Select is identifying and profiling thought leaders in colorectal and general surgery across the United States. The in-house research group at Thought Leader Select is applying its objective, validated methodology to assess the skills and experiences, as well as the clinical and research interests, of KOLs specializing in surgery of the colon, rectum, and bowels.
Known for the versatility of applications for its in-house research, Thought Leader Select’s advisory team will also plan engagement strategies to optimize the talents and contributions that the key opinion leaders will bring to several initiatives for the client company, including late-stage clinical trial work, as well as publication and speaking opportunities. The KOLs will also work on issues within appropriate regulatory bodies, as well as patient advocacy and awareness, and treatment guidelines involvement.
In addition to its work with key opinion leaders, Thought Leader Select’s research group ... read more »
TAGS: 
advisory boards basic research biopharmaceutical biotechnology centers of excellence clinical research clinical trials gastroenterological surgery gastroenterology experts gastroenterology KOLs health care professionals health care providers key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts Neil Mellor pharma pharmaceutical physicians therapeutic areas Thought Leader Select thought leaders
February 26, 2013 ·
Leave a comment
For Immediate Release
February 21, 2013 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina-based key opinion leader strategy company, announces the hiring of Heather Langan as research director.
In her new role at the company, Langan will lead profiling and engagement planning related to the skills and experience of both leading physicians and other health care professionals, as well as medical centers of excellence that advance the medical science. Life sciences companies use this research and advice for better strategic decision-making for collaborations with medical experts, as industry works with these experts to bring new treatments to market for better patient care and better public health outcomes.
Langan arrives at Thought Leader Select after a decorated career in human services, working and leading teams in developmental disabilities, family therapy, and mental health. In her most recent role at Duke University’s National Center for Child Traumatic Stress, Langan led quality assurance and continuous improvement at the premier center of excellence in the area of child trauma, influencing the treatment decisions in evidence-based clinics around the country.
Heather Langan holds two bachelor’s degrees, in philosophy and psychology, from the University of Utah. After graduation, Langan also earned a pair of master’s degrees in psychology and counseling, from Stephen F. Austin University and North ... read more »
TAGS: biopharmaceutical centers of excellence developmental disabilities Duke University family therapy health care professionals Heather Langan Human Services key opinion leaders KOL engagement KOL engagement planning KOL identification KOL profiling leading physicians medical research medicine mental health National Center for Child Traumatic Stress patient care Paul Meade public health outcomes Thought Leader Select
December 20, 2012 ·
Leave a comment
December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating chronic obstructive pulmonary disorder (COPD), approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form rosters of key opinion leaders in Canadian rheumatology and oncology circles, the company will formulate its panel of key experts in pulmonology by deploying Thought Leader Select’s team to assess the skills and experiences of physician specialists across the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs. Among these ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology chronic obstructive pulmonary disorder clinical trials COPD deep-profiling health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs medical devices Neil Mellor oncology KOLs pharmaceutical pharmaceuticals physicians pulmonology rheumatology KOLs Thought Leader Select thought leaders treatment guidelines
November 6, 2012 ·
Leave a comment
November 6, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in Canada focused on key opinion leaders and medical centers of excellence in women’s health with an international biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products aimed at improving the health of women, approached Thought Leader Select for support in a variety of collaborative efforts with leading physicians and other health care professionals at leading universities, medical schools, teaching hospitals, and specialty clinics. The key opinion leaders represent medical experts within the Canadian obstetrics and gynecology community, with areas of sub-specialty including fertility and the treatment of uterine tumors.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, to advance the science of medicine and patient care in women’s health, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening collaborative ... read more »
TAGS: biopharmaceutical company biotechnology Canadian KOLs centers of excellence Chapel Hill NC clinical research clinical trials deep-profiling drug development gynecology health care professionals health care providers healthcare key opinion leaders KOL KOL deployment KOL engagement KOL identification KOL mapping KOL profiling KOLs Kristen Smithwick medical experts medical research obstetrics scientific journal publishing Thought Leader Select thought leaders transparency treatment guidelines uterine tumors women's health
October 23, 2012 ·
Leave a comment
Industry Insights from Paul Meade, M.Sc., MPH
There are several companies that claim to identify and profile key opinion leaders in healthcare, and they using an array of methodologies and techniques to arrive at defining the practitioners who drive a given therapeutic area or disease state. And yet, while all claim to have built a better mousetrap for profiling these thought leaders, what is sadly lacking among many these vendors is quality control and good quality measures.
Notwithstanding the variety of definitions of a key opinion leader emblematic of the lack of standardization across the industry, there is also a wide variation in the quality of the output from one vendor to the next. For instance, some companies utilize automated web-crawlers (think: glorified Google Alerts) to mine public information—for the most part, scientific publications data, and simply foist upon their clients a “data dump.” The content of these data dumps is often completely devoid of sound quality control—for example, it is not uncommon for an IT-based vendor to offer up John Smith, John D. Smith, and JD Smith as three separate KOLs, when, in reality, Dr. John D. Smith is a true one-of-a-kind. Likewise, we have also seen lists where vendors may conflate Dr. David Lee from Sacramento with Dr. David Lee from Shanghai, when human researchers would see these to ... read more »
TAGS: biostatisticians biotech clinical trials disease state google alerts key opinion leaders KOL assessments KOL identification KOL profiling KOL research KOLs medical devices medical diagnostics medicine peer nomination pharmaceuticals principal investigator quality control research studies scientific journal publishing social network analysis therapeutic area thought leader activities thought leaders web crawlers
October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
TAGS: basic research biopharmaceutical industry biotechnology Brian Castle centers of excellence identification centers of excellence profiling centers of excellence strategy clinical pharmacists clinical research drug development endocrinology health care professionals key opinion leaders KOL identification KOL profiling KOL strategy long-term care medical device industry medical diagnostics medical researchers medical schools medical science medical science liaison outreach nursing obesity obesity centers of excellence obesity KOLs patient care pharmaceuticals pharmacy physician assistants physicians primary care medicine registered nurses scientific journal publishing specialty medical clinics teaching hospitals Thought Leader Select Thought Leader Select consulting group Thought Leader Select research group treatment guidelines type 1 diatbetes type 2 diabetes universities
October 11, 2012 ·
Leave a comment
Thought Leader Select is pleased to announce that Allison Murphy, an executive with nearly two decades of experience working in healthcare and biopharmaceuticals, has joined the company’s team of consultants dedicated to optimizing industry collaborations with medical experts.
Murphy comes to Thought Leader Select with a track record of success in clinical work at leading medical centers of excellence, as well as sales and medical science liaison roles at Eli Lilly and Company. A 1993 graduate of Villanova University with a degree in nursing, Murphy entered clinical practice in a role leading pediatric oncology nurse teams at New York University Lagone Medical Center, followed by a stint working as a nurse coordinator in pediatric endocrinology at Columbia Presbyterian Medical Center, also in New York.
During her time at Columbia Presbyterian, Ms. Murphy managed a practice that grew from 300 to over 2000 weekly patient visits and served as study coordinator for multiple National Institutes of Health-sponsored protocols and several phase IV clinical trial collaborations with the pharmaceutical industry.
In 2001, Murphy began an 11-year run at Eli Lilly, first working as a sales specialist on behalf of the company’s portfolio of products aimed at growth disorders to help both pediatric and adult endocrinologists. Murphy ... read more »
TAGS: Allison Murphy biopharmaceuticals Columbia Presbyterian Medical Center devices diabetes thought leaders diagnostics early-stage drug development Eli Lilly endocrinology KOL engagement KOL identification KOL profiling medical science liaison NYU Lagone Medical Center Oncology oncology KOLs pediatric endocrinology pediatric oncology product planning product strategy Thought Leader Select Thought Leader Select consulting team
October 4, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with scientific advisory boards, consulting, and medical science liaison outreach to leading physicians in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes, the company has now chosen Thought Leader Select to pinpoint the leading experts in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the area of obesity, and a suite of tools to promote collaborative work ... read more »
TAGS: advisory boards biopharmaceutical biotechnology Brian Castle clinical research drug development health care professionals health care providers healthcare key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOLs medical experts medicine obesity obesity key opinion leaders obesity specialists public health
September 27, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating type and type II diabetes, approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form a roster of key opinion leaders in Canadian endocrinology circles, the company will round out its roster of key opinion leaders by deploying Thought Leader Select’s team to assess the skills and experiences of registered nurses and clinical pharmacists around the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of registered nurses and pharmacists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs.
“Thought ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology clinical pharmacists clinical research clinical trials deep-profiling diabetes health care professionals health care providers key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling medical experts Neil Mellor pharmaceuticals registered nurses Thought Leader Select type 1 diabetes type 2 diabetes
August 16, 2012 ·
Leave a comment
Industry Insights from Brian Castle
There are many ways that life science companies approach finding the right key opinion leaders in medicine to collaborate on next-generation treatments.
Some have the privilege of retaining staff members with decades of experience, during which they get to know the top doctors in their therapeutic area or disease state. This do-it-yourself (“DIY”) method can be fraught with challenges, but it can also provide valuable insights through sound relationship building.
Other companies, to fill gaps in compliance or expertise within a given area, will contract with research organizations for their KOL work. There are now over fifty companies (and counting) engaged in some form of key opinion leader identification, profiling, mapping, or engagement planning activities, and that’s not even counting the dozens of specialty medical communications agencies and larger agencies that list medcomms as a specialty area.
Contracting with external vendors can result in great work, full of insights on the right medical professionals who can make a difference in whether a product succeeds or fails in getting in the right hands—those of patients. But it can also result in really bad work—a data dump—that basically tells the buyer nothing.
We can define bad research quite easily—you know it when you see it. It often comes from methodologies that are suspect at first glance, those that rely upon too much ... read more »
TAGS: Brian Castle clinical trials communications agencies editorial boards key opinion leaders key opinion leaders in medicine KOL identification KOL mapping KOL profiling KOL relationship building KOL research life science companies life sciences media exposure medical communications agencies medical journals medical professionals patient health public health regulatory approval reimbursement approval scientific advisory boards scientific journals Thought Leader Select thought leaders treatment guidelines
Older posts »
